Your browser doesn't support javascript.
loading
Eye and Behçet's disease.
Ksiaa, I; Abroug, N; Kechida, M; Zina, S; Jelliti, B; Khochtali, S; Attia, S; Khairallah, M.
Afiliação
  • Ksiaa I; Service d'ophtalmologie, hôpital universitaire Fattouma Bourguiba, faculté de médecine, université de Monastir, 5019 Monastir, Tunisie.
  • Abroug N; Service d'ophtalmologie, hôpital universitaire Fattouma Bourguiba, faculté de médecine, université de Monastir, 5019 Monastir, Tunisie.
  • Kechida M; Service de médecine interne, hôpital universitaire Fattouma Bourguiba, faculté de médecine, université de Monastir, Monastir, Tunisie.
  • Zina S; Service d'ophtalmologie, hôpital universitaire Fattouma Bourguiba, faculté de médecine, université de Monastir, 5019 Monastir, Tunisie.
  • Jelliti B; Service d'ophtalmologie, hôpital universitaire Fattouma Bourguiba, faculté de médecine, université de Monastir, 5019 Monastir, Tunisie.
  • Khochtali S; Service d'ophtalmologie, hôpital universitaire Fattouma Bourguiba, faculté de médecine, université de Monastir, 5019 Monastir, Tunisie.
  • Attia S; Service d'ophtalmologie, hôpital universitaire Fattouma Bourguiba, faculté de médecine, université de Monastir, 5019 Monastir, Tunisie.
  • Khairallah M; Service d'ophtalmologie, hôpital universitaire Fattouma Bourguiba, faculté de médecine, université de Monastir, 5019 Monastir, Tunisie. Electronic address: moncef.khairallah@yahoo.fr.
J Fr Ophtalmol ; 42(4): e133-e146, 2019 Apr.
Article em En | MEDLINE | ID: mdl-30850197
ABSTRACT
Behçet's disease is a chronic multisystem disorder characterized by relapsing inflammation for which the underlying histopathology is an occlusive vasculitis. The disease has a high prevalence in the Mediterranean region, Far and Middle Eastern countries. It is clinically characterized by oral and genital ulcerations, ocular inflammatory involvement, skin lesions, vascular involvement and numerous other systemic manifestations. Uveitis is by far the most common ocular manifestation of Behçet's disease. It typically presents in the form of relapsing-remitting panuveitis with retinal vasculitis that may result in severe visual loss. Management of Behçet's uveitis relies on corticosteroid therapy, conventional immunosuppressive drugs and biological agents and requires a close collaboration between ophthalmologist and internist. A better understanding of auto-inflammatory process and of the role of cytokines implicated in the pathogenesis of Behçet's disease will enable researchers to develop more specific and effective therapy.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Behçet / Olho / Fenômenos Fisiológicos Oculares Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Fr Ophtalmol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Tunísia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Behçet / Olho / Fenômenos Fisiológicos Oculares Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Fr Ophtalmol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Tunísia